Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 143 participants.
Also called NCT02178098
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 143 participants
- Registry
-
NCT02178098
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02178098. Randomized; quadruple masking; primary purpose treatment. Start 2014-06-16 (actual); primary completion 2015-05-22 (actual). Results posted on 2023-04-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension
- Condition
- Hypercholesterolemia
- Condition
- Hypertension
- Intervention (Drug)
- ETC-1002
- Intervention (Drug)
- Placebo
- Lead sponsor
- Esperion Therapeutics, Inc.
- Collaborator
- Medpace, Inc.
Record details
- Record id
cardio:ct-nct02178098- Content hash
dda0fd7cf1a77b00048e25d56d06ab4a3738fb55ed4a7dc13f8922f926867ce2